45 programming-"the"-"DAAD"-"IMPRS-ML"-"IDAEA-CSIC"-"U"-"PDI-Service" "UCL" Fellowship positions in United Kingdom
Sort by
Refine Your Search
-
About us The UCL Institute for Global Health (IGH) is at the heart of UCL’s Grand Challenge of Global Health. The Institute’s vision is for a world where international policy on global health is
-
. UCL is ranked 9th in the 2024 QS World University Rankings, 2nd in the UK for research power (Research Excellence Framework 2021) and our Neuroscience degree is ranked first in Europe (U.S. News and
-
organoid models of neurodevelopmental diseases to test advanced genetic therapies. It will be supervised by Professor Gabriele Lignani and is in collaboration with Dr Amy McTague at UCL Institute of Child
-
. UCL is ranked 9th in the 2024 QS World University Rankings, 2nd in the UK for research power (Research Excellence Framework 2021) and our Neuroscience degree is ranked first in Europe (U.S. News and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The UCL Institute for Global Health (IGH) is at the heart of UCL’s Grand Challenge of Global Health. The Institute’s vision is for a world where international policy on global health is
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and